CD44 and cancer: Additionally, CD44 is known to be a cell surface biomarker of cancer stem-like cells (CSLCs), and tumour cells with CSLC properties have high proliferative activity, clonogenic activity, tumour growth, and decreased apoptosis, and are able to survive chemotherapy [40,41].